| Nusrat Ahmad Chaudhary, MD | |
|
1700 Matthews Township Pkwy, Matthews, NC 28105-4658 | |
| (704) 841-8151 | |
| Not Available |
| Full Name | Nusrat Ahmad Chaudhary |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 1700 Matthews Township Pkwy, Matthews, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043460991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2010-00744 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Novant Health Mint Hill Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Presbyterian Hospital | 1153231907 | 359 |
News Archive
A group of 29 physicians, convened by the American Medical Associations and "mostly selected" by specialty trade groups, have the task of recommending how to divide Medicare money into payments for each service, procedure and treatment the program covers, The Wall Street Journal reports.
Although many cancer drugs have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the Topoisomerase I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, Topotecan and Irinotecan.
Facial color is suggestive of emotional states, as in the phrases: "flushed with anger" and "pale with fear." Although some behavioral studies have investigated the effects of facial color on expression, there is limited neurophysiological evidence showing the effects of facial color on emotional expression perception.
Missing a gene may be less problematic than you'd think. This is one of the conclusions that emerge from the most extensive catalogue of structural variations - changes in large sections of a person's DNA sequence - to date.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
› Verified 7 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
A group of 29 physicians, convened by the American Medical Associations and "mostly selected" by specialty trade groups, have the task of recommending how to divide Medicare money into payments for each service, procedure and treatment the program covers, The Wall Street Journal reports.
Although many cancer drugs have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the Topoisomerase I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, Topotecan and Irinotecan.
Facial color is suggestive of emotional states, as in the phrases: "flushed with anger" and "pale with fear." Although some behavioral studies have investigated the effects of facial color on expression, there is limited neurophysiological evidence showing the effects of facial color on emotional expression perception.
Missing a gene may be less problematic than you'd think. This is one of the conclusions that emerge from the most extensive catalogue of structural variations - changes in large sections of a person's DNA sequence - to date.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nusrat Ahmad Chaudhary, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: () - | Nusrat Ahmad Chaudhary, MD 1700 Matthews Township Pkwy, Matthews, NC 28105-4658 Ph: (704) 841-8151 |
News Archive
A group of 29 physicians, convened by the American Medical Associations and "mostly selected" by specialty trade groups, have the task of recommending how to divide Medicare money into payments for each service, procedure and treatment the program covers, The Wall Street Journal reports.
Although many cancer drugs have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the Topoisomerase I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, Topotecan and Irinotecan.
Facial color is suggestive of emotional states, as in the phrases: "flushed with anger" and "pale with fear." Although some behavioral studies have investigated the effects of facial color on expression, there is limited neurophysiological evidence showing the effects of facial color on emotional expression perception.
Missing a gene may be less problematic than you'd think. This is one of the conclusions that emerge from the most extensive catalogue of structural variations - changes in large sections of a person's DNA sequence - to date.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.
› Verified 7 days ago
Vidyasagargoud Marupakula, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Healing Way, Matthews, NC 28104 Phone: 980-993-2240 | |
Zelalem Atakilt Gebreananya, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-9740 Fax: 704-384-9565 | |
Dr. Henry D Cremisi, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5416 Fax: 704-384-5992 | |
Dr. Kevin M. Rudisel, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5420 Fax: 704-384-5424 | |
Dr. Abdul Karim Garuba, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9705 Northeast Pkwy Ste 400, Matthews, NC 28105 Phone: 704-844-8971 Fax: 704-844-8972 | |
Dr. Keithe Saclayan Shensky, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 Fax: 704-841-9228 |